President Biden Says He Is Determined To Ban Assault Weapons

-Reuters

-Reuters

Total
0
Shares
Related Posts
Read More

Akari Therapeutics To Present A Poster On Pre-Clinical Development Of Long-Acting PAS-Nomacopan As A Potential Treatment For Geographic Atrophy At The 4th Annual Dry AMD Therapeutic Development Conference

Akari Therapeutics, Plc (NASDAQ:AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced that Chief Scientific Officer Miles Nunn will present a

AKTX